To enable CDC to scale up its activity of investing and lending to support the building of businesses in developing countries, to create jobs and make a lasting difference to people’s lives in some of the world's poorest places. CDC is DFID’s main vehicle for investing in private companies in Africa and South Asia. CDC encourages capital investments from other private investors by being a first mover, demonstrating to other investors that commercial returns are possible in these frontier markets, and by sharing risk and expertise. The additional equity from DFID will enable CDC to meet demand for capital in its target markets and allow CDC to sustain a higher volume of more developmental investments across priority regions and business sectors
The United Kingdom's Contribution to the European Development Fund (EDF) for Aid under the Cotonou Agreement. This project was approved before the referendum on the UK’s membership of the EU. Work is now under way to understand the implications of leaving the EU for the UK’s development work
UK contribution to the 18th Replenishment of the World Bank International Development Association (IDA 18)
To reduce poverty by enabling the World Bank to provide grants and low-interest loans that enhance economic opportunities and tackle poverty in poor countries.
UK contributions to compensate IDA the costs of foregone debt service payments under the Multilateral Debt Relief Initiative (MDRI)
Reduce vaccine preventable diseases (VPDs) in poor countries in a sustainable way using innovative financing approach
To tackle the immediate impact of the three most deadly infectious diseases – HIV/AIDS, tuberculosis and malaria – and put the international community on the right track to end the three diseases as epidemics by 2030.
Gavi supports vaccine delivery in 68 of the world's poorest countries reaching 60% of the world's birth cohort. Gavi immunises children against vaccine preventable diseases including measles, rubella, meningitis, cervical cancer, pneumonia and diarrhoea. Gavi has played a significant role in the recent halving of global child mortality. Over the 2016 to 2020, Gavi will fully deliver the UK target to immunise 76 million children and save 1.4 million lives. Gavi targets reaching those in hard to reach areas, the poorest, and the most marginalised. Gavi has a major global market shaping role for vaccines, negotiating lower prices for low-income countries, and incentivising new vaccines such as for Ebola and Malaria.
To support development and poverty reduction through environmental protection, and help developing countries respond to climate change
To scale up access to treatment for HIV/Aids, Malaria and Tuberculosis for poor people by funding programmes that (often through bulk international procurement) lower the price of quality drugs and diagnostics and accelerating the pace at which they are made available.